Form 4: InfuSystem Holdings CEO Richard Dilorio Reports Stock Transactions

Richard Dilorio, CEO of InfuSystem Holdings, reports acquisition and disposal of common stock and restricted stock units.

Summary

• Richard Dilorio, the CEO of InfuSystem Holdings, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• On May 17, 2025, Dilorio acquired 40,909 shares of common stock through the vesting of restricted stock units.
• Also on May 17, 2025, Dilorio disposed of 19,509 shares of common stock at a price of $6.15.
• Following these transactions, Dilorio directly owns 447,925 shares of InfuSystem Holdings common stock.
• This total includes an additional 2,842 shares acquired recently through the Company's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the CEO's stock transactions as an indicator of management's confidence in the company.

Key Dates

Keywords

Form 4, InfuSystem Holdings, Richard Dilorio, Beneficial Ownership, Stock Transactions, Restricted Stock Units, Common Stock